Bibliography
- Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114(2):97-109
- Packer RJ, Zhou T, Holmes E, et al. Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of children’s oncology group trial A9961. Neuro Oncol 2013;15(1):97-103
- Li M, Lee KF, Lu Y, et al. Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. Cancer Cell 2009;16(6):533-46
- Korshunov A, Ryzhova M, Jones DT, et al. LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR). Acta Neuropathol 2012;124(6):875-81
- Spence T, Sin-Chan P, Picard D, et al. CNS-PNETS with C19MC amplification and/or lin28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathol 2014;128(2):291-303
- Korshunov A, Sturm D, Ryzhova M, et al. Embryonal tumor with abundant neuropil and true rosettes (etantr), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathol 2014;128(2):279-89
- Zhu H, Shyh-Chang N, Segre AV, et al. The lin28/let-7 axis regulates glucose metabolism. Cell 2011;147(1):81-94
- Spence T, Perotti C, Sin-Chan P, et al. A novel c19mc amplified cell line links lin28/let-7 to mtor signaling in embryonal tumor with multilayered rosettes. Neuro Oncol 2014;16(1):62-71
- Robertson KD. DNA methylation, methyltransferases, and cancer. Oncogene 2001;20(24):3139-55
- Ioshikhes IP, Zhang MQ. Large-scale human promoter mapping using CpG islands. Nat Genet 2000;26(1):61-3
- Suganuma T, Workman JL. Crosstalk among histone modifications. Cell 2008;135(4):604-7
- Northcott PA, Nakahara Y, Wu X, et al. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet 2009;41(4):465-72
- Schwartzentruber J, Korshunov A, Liu XY, et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012;482(7384):226-31
- Kleinman CL, Gerges N, Papillon-Cavanagh S, et al. Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR. Nat Genet 2014;46(1):39-44
- Huang J, Chen K, Huang J, et al. Regulation of the leucocyte chemoattractant receptor fpr in glioblastoma cells by cell differentiation. Carcinogenesis 2009;30(2):348-55
- Chabot GG, Rivard GE, Momparler RL. Plasma and cerebrospinal fluid pharmacokinetics of 5-Aza-2′-deoxycytidine in rabbits and dogs. Cancer Res 1983;43(2):592-7
- Galanis E, Jaeckle KA, Maurer MJ, et al. Phase ІІ trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study. J Clin Oncol 2009;27(12):2052-8
- Braiteh F, Soriano AO, Garcia-Manero G, et al. Phase І study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers. Clin Cancer Res 2008;14(19):6296-301